Monday, January 19, 2026 1/19/2026

Preventive mechanisms of Age-associated Thrombosis

Award Number: R01HL168630
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/01/2024
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Preventive mechanisms of Age-associated Thrombosis - Summary Thrombotic events such as myocardial infarction, stroke and deep vein thrombosis are the leading causes of morbidity and mortality in the elderly. The objective of this proposal is to test the usefulness of a calorie-restriction (CR) intervention to diminish prothrombotic effects in aged mice or aged mice with type 2 diabetes and identify a druggable target. Our pioneering studies have established that increased thrombotic susceptibility in aging is associated with platelet hyperactivity due to excessive accumulation of oxidants or the reactive oxygen species. We also observed that the loss in mitochondrial superoxide-dismutase (SOD2) activity within platelets increases mitochondrial-oxidant burden in aged mice and enhances platelet activation and susceptibility to arterial thrombosis. Our novel pilot data shows that sirtuin 3 (SIRT3), a mitochondrial-deacetylase that regulates the activity of several mitochondrial-proteins including SOD2 is markedly decreased in platelets from aged mice and humans. Consistent with these observations, in an ongoing clinical study, we observed that increased platelet activation in healthy older humans and obese-diabetics was overcome by pre-incubation with SIRT3 activator or a SOD2 mimetic, suggesting a Mito-oxidant dependent mechanisms. Recently, we also reported that the increased potential for venous thrombosis during aging is mediated via increased total cell-free DNA and this increase is likely due to elevation in mitochondrial DNA. The damaged circulating mitochondria with cardiolipin surface may also enhance thrombin generation potential and venous thrombosis. So, a major goal of this proposal is to determine a role of damaged-mitochondria that mediates age-associated arterial and venous thrombosis and identify preventive measures. In search for a mitochondria-based protective mechanisms, we conducted a pilot study and employed a 30% CR in aged mice or aged mice with type 2 diabetes for a month. This 30% CR increased platelet-SIRT3, decreased damage in mitochondria, decreased platelet activation and lowered thrombotic susceptibility. We hypothesize that CR protects from age-associated arterial- and venous thrombosis through distinct mitochondrial mechanisms. We will also test that the presence of insulin resistance or type two diabetes exacerbates mitochondrial damage and enhances thrombosis which is also preventable with CR. Aim 1 will focus on platelet SIRT3 activation as a protective mechanism of CR for arterial thrombosis. Aim 2 will test whether CR prevents from circulating damaged- mitochondria and mitochondrial-DNA and lowers the susceptibility to venous thrombosis. Thus, the significance of this proposal is in establishing usefulness of a healthy life-style-intervention to diminish prothrombotic effects in aging and age-associated comorbidity and identify a druggable target downstream to CR for translational application.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $620,425 )
2025	2025	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Blood Diseases and Resources Research	001	2	8/19/2025	NON-COMPETING CONTINUATION	$62,043
2025	2025	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Blood Diseases and Resources Research	000	2	12/24/2024	NON-COMPETING CONTINUATION	$558,382
														Subtotal = $620,425

Issue Date FY: 2024 ( Subtotal = $620,425 )
2024	2024	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Blood Diseases and Resources Research	000	1	12/21/2023	NEW	$558,382
2024	2024	THE UNIVERSITY OF IOWA	105 JESSUP HALL	IOWA CITY	IA	52242	JOHNSON	USA	Blood Diseases and Resources Research	001	1	6/14/2024	NEW	$62,043
														Subtotal = $620,425

Grand Total All Awards = $1,240,850

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Preventive mechanisms of Age-associated Thrombosis

Award Number: R01HL168630

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/01/2024

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer